Final answer:
When a mutant bacterial strain lacking the bacterial hexokinase gene and its promoter is engineered with a human hexokinase gene driven by a normal bacterial promoter, it will produce the human form of hexokinase.
Step-by-step explanation:
Introducing the human hexokinase gene into a mutant bacterial strain that lacks the bacterial hexokinase gene and its promoter, with the human gene being driven by a normal bacterial promoter, will produce the human form of hexokinase. The bacteria will express the introduced gene as it does its own, utilizing the components of molecular machinery it has for gene expression. As a result, the bacteria will synthesize the human version of the enzyme because they're using the human hexokinase DNA sequence to make the protein. There will not be production of the bacterial form of hexokinase, nor a hybrid enzyme, and since only the human gene sequence is present, both forms of the enzyme will not be present.